New Prescription Drug Disposal Initiative to Launch During Earth Week 2010

Monday, April 19, 2010 General News J E 4

NCPA, Sharps Compliance, and the Community Anti-Drug Coalitions of America to Announce the Program on Monday

WHAT:  The "Dispose My Meds" campaign offered by NCPA in partnership with Sharps Compliance, allows consumers unprecedented options to safely and responsibly dispose of unused medications at hundreds of participating community pharmacies nationwide. Speakers on the call will discuss the need for the program, how it works, and the progress made to date.


WHEN:  Monday, April 19, 2010 at 1:00 p.m. (ET)

DIAL-IN #:  800-944-8766 and then enter in the conference code of 90760

WHY:  More than four billion prescriptions are written annually in the U.S., according to estimates, and up to 40 percent of drugs dispensed outside of hospitals go unused, generating some 200 million pounds of pharmaceutical waste each year. Unused patient medications are a contributor to traces of pharmaceuticals being found in America's drinking water and accidental poisonings, which have involved an 80 percent increase in U.S. deaths from accidental overdose of narcotics in a recent six-year period. The 2010 Dispose My Meds campaign is an official Earth Day activity.


Joe Harmison, PD, NCPA President and Arlington, TX pharmacy owner

Claude Dance, Sharps Compliance, Inc. Senior Vice President, Sales & Marketing

Mary Elizabeth Elliott, Community Anti-Drug Coalitions of America Vice President, Communications, Membership and Information Technology

CONTACT:  For more information or to RSVP, please contact John Norton, NCPA, at +1-703-600-1174 or

/PRNewswire-USNewswire -- April 19/

SOURCE National Community Pharmacists Association



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Curemark to Present at the Rodman & Renshaw Global...
Celtic Pharma Announces Preclinical Findings that ...